Answers are grounded in this paper and cite their sources.
Wilson's disease (WD) is a rare inherited disorder of copper metabolism with pathological copper hyperaccumulation in some vital organs. However, the clinical diagnosis technique of WD is complicated, aggressive, and time‐consuming. In this work, a novel ratiometric photoacoustic (PA) imaging nanoprobe in the NIR‐II window is developed to achieve noninvasive, rapid, and accurate Cu 2+ quantitative detection in vitro and in vivo. The nanoprobe consists of Cu 2+ ‐responsive IR970 dye and a nonresponsive palladium‐coated gold nanorod (AuNR‐Pd), achieving a concentration‐dependent ratiometric PA 970 /PA 1260 signal change. The urinary Cu 2+ content is detectable within minutes down to a detection limit of 76 × 10 −9 m . This report acquisition time is several orders of magnitude shorter than those of existing detection approaches requiring complex procedure. Moreover, utilizing the ratiometric PA nanoprobe, PA imaging enables biopsy‐free measurement of the liver Cu 2+ content and visualization of the liver Cu 2+ biodistribution of WD patient, which avoid the body injury during the clinical Cu 2+ test using liver biopsy method. The NIR‐II ratiometric PA detection method is simple and noninvasive with super precision, celerity, and simplification, which holds great promise as an alternative to liver biopsy for clinical diagnosis of WD.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: